CanadaBis Capital Inc.

CANB

CA13530Q1046

Drug Retailers

Market Closed - Toronto S.E. Other stock markets 03:51:28 2024-05-03 pm EDT			5-day change	1st Jan Change
0.07 ^CAD	-6.67%		-6.67%	-72.55%

Apr. 23	CanadaBis Capital Unveils New 60%+ Double-Infused Pre-Roll Under Dab Bods Brand; Says "Setting New Standard" For THC Potency In Canada Market	MT
Apr. 23	Canadabis Capital Inc. Unveils New 60%+ Double- Infused Pre-Roll Under Dab Bods Brand	CI

CanadaBis Capital Inc. Provides Sales Guidance for the Next Quarter

June 23, 2022 at 06:48 pm EDT

CanadaBis Capital Inc.'s positive sales performance in third quarter of 2022 is expected carry forward into the next quarter based on sustained high demand and increased purchase orders on new products such as moon rocks, infused pre-rolls, live resin vapes and high CBD cartridges.

Latest news about CanadaBis Capital Inc.

CanadaBis Capital Unveils New 60%+ Double-Infused Pre-Roll Under Dab Bods Brand; Says "Setting New Standard" For THC Potency In Canada Market	Apr. 23	MT
Canadabis Capital Inc. Unveils New 60%+ Double- Infused Pre-Roll Under Dab Bods Brand	Apr. 23	CI
CanadaBis Capital, With Sub Stigma Grow, Fiscal Q2 2024 Net Revs Down On Prior Quarter; CANB Down Near 40%, Hit Fresh 52 Week Lows; Separately Confirms No Material Change	Apr. 01	MT
CanadaBis Capital Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	Mar. 29	CI
CanadaBis Capital's Fiscal Q1 Profit, Revenue Grows	Jan. 02	MT
CanadaBis Capital Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023	Dec. 29	CI
CanadaBis Capital's Fiscal Q4 Profit, Revenue Rises; Up 5%	Nov. 29	MT
CanadaBis Capital's Fiscal Q4 Profit, Revenue Rises	Nov. 29	MT
CanadaBis Capital Inc. Reports Earnings Results for the Full Year Ended July 31, 2023	Nov. 27	CI
CanadaBis Capital CFO Steps Down, Replacement Appointed	23-09-01	MT
CanadaBis Capital Inc. Announces Appointment of Garfield Richards as Chief Financial Officer	23-08-31	CI
CanadaBis Capital's Fiscal Q3 Profit, Net Revenue Grows; Provides Outlook; Up 10.7%	23-06-29	MT
CanadaBis Capital's Fiscal Q3 Profit, Net Revenue Grows; Provides Outlook	23-06-29	MT
CanadaBis Capital Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	23-06-27	CI
Canadabis Capital Inc. Launches New Super Slim Style Pre Roll Line	23-06-19	CI
Canadabis Capital Appoints Nicole Bacsalmasi Ll.B to the Board	23-06-01	CI
CanadaBis Capital Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	23-03-31	CI
CanadaBis Capital Says Intends to Introduce More Products in 2023, Expects Sales Growth to Continue	23-01-24	MT
CanadaBis Capital Swings to Q1 Net Income from Year-Ago Loss; Net Revenue $5.15 Million Vs $1.85 Million	23-01-03	MT
CanadaBis Capital Inc. Reports Earnings Results for the First Quarter Ended October 31, 2022	22-12-29	CI
CanadaBis Capital Inc. Reports Earnings Results for the Full Year Ended July 31, 2022	22-11-28	CI
CanadaBis Capital Inc. Auditor Raises 'Going Concern' Doubt	22-11-27	CI
CanadaBis Capital Swings to Q3 Net Income from Year-Ago Loss; Revenue Rises	22-06-24	MT
CanadaBis Capital Inc. Provides Sales Guidance for the Next Quarter	22-06-23	CI
CanadaBis Capital Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	22-06-23	CI

Chart CanadaBis Capital Inc.

Duration

Period

More charts

Company Profile

CanadaBis Capital Inc. is a vertically integrated Canadian cannabis company. The Companyâs principal business is the production and sale of recreational cannabis and cannabis extracts. The Company operates through three segments: Cultivation and wholesale, Retail and Extract. The Cultivation and wholesale segment is engaged in cultivating and distributing cannabis and cannabis products to and through, provincial liquor and cannabis boards, which are subsequently sold to end consumers. Its Retail segment is involved in the sale of cannabis and cannabis related products to end consumers on premise owned and operated by the Company. Its Extract segment provides cannabinoid extraction services for the Company and also to other licensed producers. The Companyâs subsidiaries include Stigma Pharmaceuticals Inc., 1998643 Alberta Ltd., Full Spectrum Labs Ltd., 2103157 Alberta Ltd., and Goldstream Cannabis Inc.

Sector

Drug Retailers

Calendar

2024-06-26 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Cannabis Product Retailers

	1st Jan change	Capi.
CANADABIS CAPITAL INC.	-72.55%	7.07M
VERANO HOLDINGS CORP.	+18.20%	1.75B
GLASS HOUSE BRANDS INC.	+103.17%	688M
TERRASCEND CORP.	+9.09%	511M
HIGH TIDE INC.	+39.44%	172M
MARIMED INC.	+9.17%	114M
CANTOURAGE GROUP SE	+4.46%	101M
NOVA CANNABIS INC.	+59.55%	59.49M

Cannabis Product Retailers